Royalty Pharma plc
RPRX
$31.28
$0.110.35%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 987.23M | 998.55M | 1.80B | 872.00M | 495.31M |
| Total Receivables | 810.73M | 790.67M | 773.68M | 682.71M | 760.84M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.19M | 4.97M | 2.29M | 5.01M | 18.04M |
| Total Current Assets | 1.80B | 1.79B | 2.58B | 1.56B | 1.27B |
|
|
|||||
| Total Current Assets | 1.80B | 1.79B | 2.58B | 1.56B | 1.27B |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 5.32M | 5.32M | 5.32M | -- | 1.78M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 15.16B | 15.01B | 13.91B | 13.47B | 14.09B |
| Total Assets | 18.22B | 18.04B | 17.66B | 16.13B | 16.38B |
|
|
|||||
| Total Accounts Payable | 13.37M | 22.06M | 23.42M | 11.55M | 15.17M |
| Total Accrued Expenses | 98.06M | 38.41M | 56.25M | 12.60M | 51.68M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 997.77M | 996.94M | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 144.41M | 110.35M | 196.03M | 100.43M | 94.53M |
| Total Other Current Liabilities | 144.41M | 110.35M | 196.03M | 100.43M | 94.53M |
| Total Current Liabilities | 1.25B | 1.17B | 275.70M | 124.57M | 161.38M |
|
|
|||||
| Total Current Liabilities | 1.25B | 1.17B | 275.70M | 124.57M | 161.38M |
| Long-Term Debt | 6.61B | 6.61B | 7.60B | 6.14B | 6.14B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.08M | 5.58M | 27.04M | 3.22M | 900.00K |
| Total Liabilities | 7.88B | 7.78B | 7.90B | 6.27B | 6.30B |
|
|
|||||
| Common Stock & APIC | 4.10B | 4.11B | 4.10B | 4.07B | 4.01B |
| Retained Earnings | 2.85B | 2.76B | 2.38B | 2.43B | 2.52B |
| Treasury Stock & Other | -2.66M | -2.66M | -2.66M | -2.65M | -2.63M |
| Total Common Equity | 6.95B | 6.87B | 6.48B | 6.50B | 6.53B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.95B | 6.87B | 6.48B | 6.50B | 6.53B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 3.40B | 3.39B | 3.28B | 3.36B | 3.56B |
| Total Equity | 10.34B | 10.26B | 9.75B | 9.86B | 10.08B |
|
|
|||||
